9,10-dimethyl-1,2-benzanthracene has been researched along with Myoepithelial Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baffi, MO; Chen, DT; Crowley, MR; Frost, A; Nicola, T; Serra, R | 1 |
| Rehm, S | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Myoepithelial Tumor
| Article | Year |
|---|---|
Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Carcinoma, Squamous Cell; Cell Differentiation; Female; Genes, Dominant; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Myoepithelioma; Pituitary Hormones; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta | 2006 |
Chemically induced mammary gland adenomyoepitheliomas and myoepithelial carcinomas of mice. Immunohistochemical and ultrastructural features.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Actins; Adenocarcinoma; Animals; Female; Immunohistochemistry; Keratins; Mammary Neoplasms, Experimental; Mice; Microscopy, Electron; Myoepithelioma | 1990 |